LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, today announced continued progress in developing its mobile healthcare application ecosystem, including applications being prepared for anticipated future availability through the Apple App Store and Google Play Store. The company also revealed that early-stage platform subscribers have surpassed 1,000, signaling early interest in its telehealth and healthcare analytics platforms targeting emerging markets.
According to the company, the applications under development are designed to support telehealth, healthcare communication, patient engagement, provider coordination, emergency response, and AI-assisted healthcare support initiatives as part of LataMed's broader digital healthcare infrastructure strategy. Management stated that development, testing, integration, and platform optimization efforts are ongoing for multiple mobile healthcare applications intended to improve healthcare accessibility and digital coordination throughout emerging markets, including Latin America.
The company further noted that certain applications are being prepared for anticipated future submission and availability through the Apple App Store and Google Play Store, subject to continued development, internal testing, platform review processes, and applicable regulatory considerations. Surpassing 1,000 early-stage platform subscribers reflects continued early interest and engagement with the LataMed AI healthcare technology ecosystem, which management believes may provide valuable operational feedback as development progresses.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: 'We are continuing to advance development of our mobile healthcare application ecosystem with the goal of expanding accessibility and healthcare connectivity through both Apple and Android mobile platforms. Surpassing 1,000 early-stage users represents an encouraging milestone as we continue refining and expanding our broader digital healthcare infrastructure initiatives.'
LataMed AI's broader technology initiatives remain focused on scalable healthcare infrastructure solutions for underserved and developing markets where access to healthcare coordination, telehealth services, and digital healthcare tools may be limited or fragmented. The company emphasized that the applications and related platform technologies remain under active development and have not yet been fully commercialized or broadly deployed. No assurance can be provided regarding the timing of any public release, App Store or Google Play availability, regulatory progression, commercialization initiatives, future platform functionality, or operational success.
For more information, please visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
